CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis

MLA

Andreas S Papazoglou, et al. “CERT2 Ceramide- and Phospholipid-Based Risk Score and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis.” Journal of Clinical Lipidology, vol. 16, no. 3, Aug. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0fa96c2a4c624af20d1ebb639a4605ff&authtype=sso&custid=ns315887.

APA

Andreas S Papazoglou, Nikolaos Stalikas, Dimitrios V Moysidis, Nikolaos Otountzidis, Anastasios Kartas, Efstratios Karagiannidis, George Giannakoulas, & Georgios Sianos. (2021). CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis. Journal of Clinical Lipidology, 16(3).

Chicago

Andreas S Papazoglou, Nikolaos Stalikas, Dimitrios V Moysidis, Nikolaos Otountzidis, Anastasios Kartas, Efstratios Karagiannidis, George Giannakoulas, and Georgios Sianos. 2021. “CERT2 Ceramide- and Phospholipid-Based Risk Score and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis.” Journal of Clinical Lipidology 16 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0fa96c2a4c624af20d1ebb639a4605ff&authtype=sso&custid=ns315887.